Your browser doesn't support javascript.
loading
Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage.
Cheng, Nuo; Wang, Hong; Zou, Ming; Jin, Wei-Na; Shi, Fu-Dong; Shi, Kaibin.
Afiliação
  • Cheng N; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Wang H; Department of Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zou M; Department of Neurosurgery, Zhongda Hospital, Southeast University, Nanjing, China.
  • Jin WN; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
  • Shi FD; Department of Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Shi K; Department of Neurology, Institute of Neuroimmunology, Tianjin Medical University General Hospital, Tianjin, China.
J Cereb Blood Flow Metab ; 42(11): 2048-2057, 2022 11.
Article em En | MEDLINE | ID: mdl-35861238
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_cerebrovascular_disease Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Limite: Animals / Humans Idioma: En Revista: J Cereb Blood Flow Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_cerebrovascular_disease Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Limite: Animals / Humans Idioma: En Revista: J Cereb Blood Flow Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China